Sustained Release of Dexamethasone from 3D-Printed Scaffolds Modulates Macrophage Activation and Enhances Osteogenic Differentiation
- PMID: 38016086
- PMCID: PMC10726309
- DOI: 10.1021/acsami.3c09774
Sustained Release of Dexamethasone from 3D-Printed Scaffolds Modulates Macrophage Activation and Enhances Osteogenic Differentiation
Abstract
Enhancing osteogenesis via modulating immune cells is emerging as a new approach to address the current challenges in repairing bone defects and fractures. However, much remains unknown about the crosstalk between immune cells and osteolineage cells during bone formation. Moreover, biomaterial scaffold-based approaches to effectively modulate this crosstalk to favor bone healing are also lacking. This study is the first to investigate the interactions between macrophages and mesenchymal stem cells (MSCs) in co-cultures with the sustained release of an anti-inflammatory and pro-osteogenesis drug (dexamethasone) from three-dimensional (3D)-printed scaffolds. We successfully achieved the sustained release of dexamethasone from polycaprolactone (PCL) by adding the excipient-sucrose acetate isobutyrate (SAIB). Dexamethasone was released over 35 days in the 17-163 nM range. The osteogenic differentiation of MSCs was enhanced by M1 macrophages at early time points. The late-stage mineralization was dominated by dexamethasone, with little contribution from the macrophages. Besides confirming BMP-2 whose secretion was promoted by both dexamethasone and M1 macrophages as a soluble mediator for enhanced osteogenesis, IL-6 was found to be a possible new soluble factor that mediated osteogenesis in macrophage-MSC co-cultures. The phenotype switching from M1 to M2 was drastically enhanced by the scaffold-released dexamethasone but only marginally by the co-cultured MSCs. Our results offer new insight into macrophage-MSC crosstalk and demonstrate the potential of using drug-release scaffolds to both modulate inflammation and enhance bone regeneration.
Keywords: 3D printing; controlled-release; dexamethasone; immunomodulation; macrophages; mesenchymal stem cells; tissue engineering.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
Similar articles
-
The 3D-Printed Ordered Bredigite Scaffold Promotes Pro-Healing of Critical-Sized Bone Defects by Regulating Macrophage Polarization.Int J Nanomedicine. 2023 Feb 20;18:917-932. doi: 10.2147/IJN.S393080. eCollection 2023. Int J Nanomedicine. 2023. PMID: 36844434 Free PMC article.
-
Coculture with monocytes/macrophages modulates osteogenic differentiation of adipose-derived mesenchymal stromal cells on poly(lactic-co-glycolic) acid/polycaprolactone scaffolds.J Tissue Eng Regen Med. 2019 May;13(5):785-798. doi: 10.1002/term.2826. Epub 2019 Apr 5. J Tissue Eng Regen Med. 2019. PMID: 30771241 Free PMC article.
-
Macrophage type modulates osteogenic differentiation of adipose tissue MSCs.Cell Tissue Res. 2017 Aug;369(2):273-286. doi: 10.1007/s00441-017-2598-8. Epub 2017 Mar 30. Cell Tissue Res. 2017. PMID: 28361303 Free PMC article.
-
Fibrinogen and magnesium combination biomaterials modulate macrophage phenotype, NF-kB signaling and crosstalk with mesenchymal stem/stromal cells.Acta Biomater. 2020 Sep 15;114:471-484. doi: 10.1016/j.actbio.2020.07.028. Epub 2020 Jul 18. Acta Biomater. 2020. PMID: 32688091
-
Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy.Inflamm Regen. 2023 May 25;43(1):29. doi: 10.1186/s41232-023-00279-1. Inflamm Regen. 2023. PMID: 37231450 Free PMC article. Review.
Cited by
-
Interplay between mesenchymal stem cells and macrophages: Promoting bone tissue repair.World J Stem Cells. 2024 Apr 26;16(4):375-388. doi: 10.4252/wjsc.v16.i4.375. World J Stem Cells. 2024. PMID: 38690513 Free PMC article. Review.
-
Drug-Loaded Bioscaffolds for Osteochondral Regeneration.Pharmaceutics. 2024 Aug 21;16(8):1095. doi: 10.3390/pharmaceutics16081095. Pharmaceutics. 2024. PMID: 39204440 Free PMC article. Review.
References
-
- Prasopthum A.; Cooper M.; Shakesheff K. M.; Yang J. Three-Dimensional Printed Scaffolds with Controlled Micro-/Nanoporous Surface Topography Direct Chondrogenic and Osteogenic Differentiation of Mesenchymal Stem Cells. ACS Appl. Mater. Interfaces 2019, 11 (21), 18896–18906. 10.1021/acsami.9b01472. - DOI - PubMed
LinkOut - more resources
Full Text Sources
